We aimed to investigate in a clinical setting, the effects of different classes of psychotropic drugs on cardiac electrophysiological measures linked with an increased risk of sudden cardiac death.
Methods:
We conducted a cross-sectional study in a population of 1059 psychiatric inpatients studying the effects of various psychotropic drugs on the T-peak to T-end (TpTe) interval, QT dispersion and QT interval.
Results:
Methadone use showed a strong association with TpTe prolongation (odds ratio (OR)=12.66 (95% confidence interval (CI), 3.9–41.1), p<0.001), an effect independent from action on QT interval. Mood stabilisers showed significant effects on ventricular repolarisation: lithium was associated with a TpTe prolongation (OR=2.12 (95% CI, 1.12–4), p=0.02), while valproic acid with a TpTe reduction (OR=0.6 (95% CI, 0.37–0.98), p=0.04). Among antipsychotics, clozapine increased TpTe (OR=9.5 (95% CI, 2.24–40.39), p=0.002) and piperazine phenothiazines increased QT dispersion (OR=2.73 (95% CI, 1.06–7.02), p=0.037).
Conclusions:
Treatment with psychotropic drugs influences TpTe and QT dispersion. These parameters might be considered to better estimate the sudden cardiac death risk related to specific medications. Beyond antipsychotics and antidepressants, mood stabilisers determine significant effects on ventricular repolarisation.
AcciavattiTMartinottiGdi GiannantonioM (2016) Sudden cardiac death related to antipsychotics: Beyond the long QT syndrome hypothesis. J Clin Psychiatry77: e600.
2.
AltinbasKGuloksuzSCaglarIM. (2014) Electrocardiography changes in bipolar patients during long-term lithium monotherapy. Gen Hosp Psychiatry36: 694–697.
3.
BarrCSNaasAFreemanM. (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet343: 327–329.
4.
CastroVMClementsCCMurphySN. (2013) QT interval and antidepressant use: A cross sectional study of electronic health records. BMJ346: f288.
5.
CorrellCUHarrisJFigenV. (2011) Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: Results from a nested case-control study. J Child Adolesc Psychopharmacol21: 365–368.
6.
de BruyneMCHoesAWKorsJA. (1998) QTc dispersion predicts cardiac mortality in the elderly. The Rotterdam study. Circulation97: 467–472.
7.
FanoeSKristensenDFink-JensenA. (2014) Risk of arrhythmia induced by psychotropic medications: A proposal for clinical management. Eur Heart J35: 1306–1315.
8.
HaddadPMAndersonIM (2002) Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs62: 1649–1671.
9.
HasnainMViewegWV (2014) QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: A comprehensive review. CNS Drugs28: 887–920.
10.
HonkolaJHookanaEMalinenS. (2012) Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J33: 745–751.
11.
HuikuriHVCastellanosAMyerburgRJ (2001) Sudden death due to cardiac arrhythmias. N Engl J Med345: 1473–1482.
12.
IfteniPCorrellCUBurteaV. (2014) Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients. Schizophr Res155: 72–76.
13.
KurtEEmulMOzbulutO. (2009) Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar affective patients on valproate or lithium-valproate maintenance therapy with healthy controls. J Psychopharmacol23: 328–333.
14.
MalikMBatchvarovVN (2000) Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol36: 1749–1766.
15.
MartinJACampbellAKillipT. (2011) QT interval screening in methadone maintenance treatment: Report of a SAMHSA expert panel. J Addict Dis30: 283–306.
16.
NielsenJAndersenMPGraffC. (2010) The effect of sertindole on QTD and TPTE. Acta Psychiatr Scand121: 385–388.
17.
NielsenJMatzJMittouxA. (2015) Cardiac effects of sertindole and quetiapine: Analysis of ECGs from a randomized double-blind study in patients with schizophrenia. Eur Neuropsychopharmacol25: 303–311.
18.
NosèMBarbuiC (2008) A simple approach to manage dosages in drug-epidemiology research. Epidemiol Psichiatr Soc17: 186–187.
19.
NosèMBighelliICastellazziM. (2015) Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study. Epidemiol Psychiatr Sci25: 532–540.
20.
NovotnyTFlorianovaACeskovaE. (2007) Monitoring of QT interval in patients treated with psychotropic drugs. Int J Cardiol117: 329–332.
21.
OzekiYFujiiKKurimotoN. (2010) QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry34: 401–405.
22.
PanikkathRReinierKUy-EvanadoA. (2011) Prolonged Tpeak-to-Tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ Arrhythm Electrophysiol4: 441–447.
23.
PerkiömäkiJSKoistinenMJYli-MäyryS. (1995) Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol26: 174–179.
24.
PiotrovskyV (2005) Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation. AAPS J7: E609–E624.
25.
RayWAChungCPMurrayKT. (2009) Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med360: 225–235.
26.
RayWAMeredithSThapaPB. (2001) Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry58: 1161–1167.
27.
RayWAMeredithSThapaPB. (2004) Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther75: 234–241.
28.
ReillyJGAyisSAFerrierIN. (2000) QTc- interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet355: 1048–1052.
29.
RisgaardBWaagsteinKWinkelBG. (2015) Sudden cardiac death in young adults with previous hospital-based psychiatric inpatient and outpatient treatment: A nationwide cohort study from Denmark. J Clin Psychiatry76: 1122– 1129.
30.
SalvoFParienteAShakirS. (2016) Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies. Clin Pharmacol Ther99: 306–314.
31.
SchneeweissSAvornJ (2009) Antipsychotic agents and sudden cardiac death — how should we manage the risk?N Engl J Med360: 294–296.
32.
StrausSMJMKorsJADe BruinML. (2006) Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol47: 362–367.
33.
TalatiSNAslamAFVasavadaB (2009) Sinus node dysfunction in association with chronic lithium therapy: a case report and review of literature. Am J Ther16: 274–278.
34.
WellensHJSchwartzPJLindemansFW. (2014) Risk stratification for sudden cardiac death: Current status and challenges for the future. Eur Heart J35: 1642–1651.
35.
WhangWKubzanskyLDKawachiI. (2009) Depression and risk of sudden cardiac death and coronary heart disease in women: Results from the Nurses’ Health Study. J Am Coll Cardiol53: 950–958.
36.
World Health Organization, Collaborating Centre for Drug Statistic Methodology (2009) Guidelines for ATC classification and DDD assignment. Oslo: World Health Organization.
37.
XiaYLiangYKongstadO. (2005) In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine. Heart Rhythm2: 162–169.
